• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过共价二聚化提高促红细胞生成素肽模拟物的效力。

Increased potency of an erythropoietin peptide mimetic through covalent dimerization.

作者信息

Wrighton N C, Balasubramanian P, Barbone F P, Kashyap A K, Farrell F X, Jolliffe L K, Barrett R W, Dower W J

机构信息

Affymax Research Institute, Palo Alto, CA 94304, USA.

出版信息

Nat Biotechnol. 1997 Nov;15(12):1261-5. doi: 10.1038/nbt1197-1261.

DOI:10.1038/nbt1197-1261
PMID:9359108
Abstract

We have synthesized a chemically defined, dimeric form of an erythropoietin mimetic peptide (EMP) that displays 100-fold increased affinity for the erythropoietin receptor (EPOR) and correspondingly elevated potency in cell-based assays and in mice. The dimeric EMP1 was synthesized using a C-terminal lysine residue as a branch point. A beta-alanine residue was coupled to the main-chain (alpha) amino group of the lysine residue in order to provide a pseudosymmetrical scaffold where both the side-chain and main-chain were of approximately equal length. Using an orthogonal protection system, independently disulphide-cylized EMP1 moieties were synthesized upon this scaffold. The proposed mechanism of increased potency of the dimer over the parental compound EMP1 is consistent with the structure of a cocrystal of EMP1 and the extracellular domain of the EPOR in which a noncovalent peptide dimer is seen spanning the cleft between two molecules of the EPOR extracellular domain.

摘要

我们合成了一种化学结构明确的促红细胞生成素模拟肽(EMP)二聚体形式,其对促红细胞生成素受体(EPOR)的亲和力提高了100倍,在基于细胞的试验和小鼠实验中相应地增强了效力。二聚体EMP1是利用C末端赖氨酸残基作为分支点合成的。将一个β-丙氨酸残基连接到赖氨酸残基的主链(α)氨基上,以提供一个假对称支架,其中侧链和主链长度大致相等。使用正交保护系统,在此支架上合成了独立的二硫键环化的EMP1部分。所提出的二聚体相对于亲本化合物EMP1效力增强的机制与EMP1和EPOR细胞外结构域的共晶体结构一致,在该共晶体中可以看到一个非共价肽二聚体跨越EPOR细胞外结构域两个分子之间的裂隙。

相似文献

1
Increased potency of an erythropoietin peptide mimetic through covalent dimerization.通过共价二聚化提高促红细胞生成素肽模拟物的效力。
Nat Biotechnol. 1997 Nov;15(12):1261-5. doi: 10.1038/nbt1197-1261.
2
Peptide agonists of the thrombopoietin receptor.
Stem Cells. 1998;16 Suppl 2:21-9. doi: 10.1002/stem.5530160705.
3
Hormone peptidomimetics: seeing double.
Nat Biotechnol. 1997 Nov;15(12):1244-5. doi: 10.1038/nbt1197-1244.
4
Characterization of new multimeric erythropoietin receptor agonists.新型多聚体促红细胞生成素受体激动剂的特性研究
Biopolymers. 2008;90(4):496-502. doi: 10.1002/bip.20959.
5
Identification of a 13 amino acid peptide mimetic of erythropoietin and description of amino acids critical for the mimetic activity of EMP1.促红细胞生成素的一种13氨基酸肽模拟物的鉴定以及对EMP1模拟活性至关重要的氨基酸的描述。
Biochemistry. 1998 Mar 17;37(11):3699-710. doi: 10.1021/bi971956y.
6
Multivalency - a way to enhance binding avidities and bioactivity - preliminary applications to EPO.多价性——一种增强结合亲和力和生物活性的方法——对促红细胞生成素的初步应用。
J Pept Sci. 2007 Sep;13(9):581-7. doi: 10.1002/psc.794.
7
An antagonist peptide-EPO receptor complex suggests that receptor dimerization is not sufficient for activation.一种拮抗剂肽 - 促红细胞生成素受体复合物表明受体二聚化不足以激活。
Nat Struct Biol. 1998 Nov;5(11):993-1004. doi: 10.1038/2965.
8
Shared and unique determinants of the erythropoietin (EPO) receptor are important for binding EPO and EPO mimetic peptide.促红细胞生成素(EPO)受体的共同和独特决定因素对于结合EPO和EPO模拟肽很重要。
J Biol Chem. 1999 May 14;274(20):14163-9. doi: 10.1074/jbc.274.20.14163.
9
A high-throughput assay to identify compounds that can induce dimerization of the erythropoietin receptor.一种用于鉴定可诱导促红细胞生成素受体二聚化的化合物的高通量检测方法。
Anal Biochem. 2000 Feb 1;278(1):39-45. doi: 10.1006/abio.1999.4408.
10
Dimerization of the erythropoietin receptor transmembrane domain in micelles.红细胞生成素受体跨膜结构域在微团中的二聚化。
J Mol Biol. 2007 Feb 16;366(2):517-24. doi: 10.1016/j.jmb.2006.11.035. Epub 2006 Nov 11.

引用本文的文献

1
Development of Novel Paclitaxel-Loaded ZIF-8 Metal-Organic Framework Nanoparticles Modified with Peptide Dimers and an Evaluation of Its Inhibitory Effect against Prostate Cancer Cells.新型肽二聚体修饰的载紫杉醇ZIF-8金属有机框架纳米颗粒的研制及其对前列腺癌细胞抑制作用的评价
Pharmaceutics. 2023 Jul 3;15(7):1874. doi: 10.3390/pharmaceutics15071874.
2
Multivalent effect of peptide functionalized polymeric nanoparticles towards selective prostate cancer targeting.肽功能化聚合物纳米颗粒对前列腺癌的多价靶向作用。
Nanoscale Adv. 2023 Jan 17;5(5):1378-1385. doi: 10.1039/d2na00601d. eCollection 2023 Feb 28.
3
Trends in peptide drug discovery.
肽类药物研发趋势。
Nat Rev Drug Discov. 2021 Apr;20(4):309-325. doi: 10.1038/s41573-020-00135-8. Epub 2021 Feb 3.
4
1,3-Dichloroacetone: A Robust Reagent for Preparing Bicyclic Peptides.1,3-二氯丙酮:一种用于制备双环肽的强大试剂。
ACS Omega. 2020 Jan 17;5(4):1840-1850. doi: 10.1021/acsomega.9b03152. eCollection 2020 Feb 4.
5
A Generalizable Platform for the Photoactivation of Cell Surface Receptors.一种可推广的细胞表面受体光激活平台。
ACS Chem Biol. 2015 Nov 20;10(11):2435-40. doi: 10.1021/acschembio.5b00372. Epub 2015 Aug 28.
6
EPOR-Based Purification and Analysis of Erythropoietin Mimetic Peptides from Human Urine by Cys-Specific Cleavage and LC/MS/MS.基于促红细胞生成素受体的人尿促红细胞生成素模拟肽的纯化与分析:半胱氨酸特异性切割及液相色谱串联质谱法
J Am Soc Mass Spectrom. 2015 Sep;26(9):1617-25. doi: 10.1007/s13361-015-1189-8. Epub 2015 Jun 30.
7
Combinatorial peptide libraries: mining for cell-binding peptides.组合肽库:筛选细胞结合肽
Chem Rev. 2014 Jan 22;114(2):1020-81. doi: 10.1021/cr400166n. Epub 2013 Dec 3.
8
Erythropoiesis stimulating agents: approaches to modulate activity.促红细胞生成素刺激剂:调节活性的方法。
Biologics. 2013;7:161-74. doi: 10.2147/BTT.S45971. Epub 2013 Jul 3.
9
Macrocyclic chelator assembled RGD multimers for tumor targeting.大环螯合剂组装的 RGD 多聚体用于肿瘤靶向。
Bioorg Med Chem Lett. 2011 Jun 1;21(11):3423-6. doi: 10.1016/j.bmcl.2011.03.110. Epub 2011 Apr 5.
10
Directed evolution of a three-finger neurotoxin by using cDNA display yields antagonists as well as agonists of interleukin-6 receptor signaling.通过使用 cDNA 展示技术对三指神经毒素进行定向进化,产生了白细胞介素 6 受体信号的拮抗剂和激动剂。
Mol Brain. 2011 Jan 7;4:2. doi: 10.1186/1756-6606-4-2.